144 related articles for article (PubMed ID: 2475111)
1. 20 KDa homologous restriction factor of complement resembles T cell activating protein.
Okada H; Nagami Y; Takahashi K; Okada N; Hideshima T; Takizawa H; Kondo J
Biochem Biophys Res Commun; 1989 Aug; 162(3):1553-9. PubMed ID: 2475111
[TBL] [Abstract][Full Text] [Related]
2. Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells.
Hideshima T; Okada N; Okada H
Immunology; 1990 Mar; 69(3):396-401. PubMed ID: 1690178
[TBL] [Abstract][Full Text] [Related]
3. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection.
Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
Eur J Immunol; 1992 Jul; 22(7):1943-6. PubMed ID: 1378024
[TBL] [Abstract][Full Text] [Related]
4. Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20.
Okada N; Harada R; Taguchi R; Okada H
Biochem Biophys Res Commun; 1989 Oct; 164(1):468-73. PubMed ID: 2803313
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.
Nose M; Katoh M; Okada N; Kyogoku M; Okada H
Immunology; 1990 Jun; 70(2):145-9. PubMed ID: 1695609
[TBL] [Abstract][Full Text] [Related]
6. Antisense sequences of 20-kDa homologous restriction factor (HRF20) are found in C9 and the C8 beta chain of homologous complement.
Campbell W; Baranyi L; Okada N; Okada H
Antisense Res Dev; 1993; 3(3):291-4. PubMed ID: 7506958
[TBL] [Abstract][Full Text] [Related]
7. Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor.
Okada N; Harada R; Okada H
Clin Exp Immunol; 1990 Apr; 80(1):109-13. PubMed ID: 1691059
[TBL] [Abstract][Full Text] [Related]
8. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
Davies A; Simmons DL; Hale G; Harrison RA; Tighe H; Lachmann PJ; Waldmann H
J Exp Med; 1989 Sep; 170(3):637-54. PubMed ID: 2475570
[TBL] [Abstract][Full Text] [Related]
9. HRF20, a membrane inhibitor of complement attack, does not protect cells from the cytotoxic reaction by lymphokine activated killer cells.
Okada H; Okada N; Hideshima T
Biochem Biophys Res Commun; 1990 Sep; 171(2):717-21. PubMed ID: 1698362
[TBL] [Abstract][Full Text] [Related]
10. Purification of 1F5 antigen that prevents complement attack on homologous cell membranes.
Harada R; Okada N; Fujita T; Okada H
J Immunol; 1990 Mar; 144(5):1823-8. PubMed ID: 2307842
[TBL] [Abstract][Full Text] [Related]
11. The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence.
Fossum S; Mallett S; Barclay AN
Eur J Immunol; 1991 Mar; 21(3):671-9. PubMed ID: 2009910
[TBL] [Abstract][Full Text] [Related]
12. Characterization of homologous restriction factor (HRF20) in human skin and leucocytes.
Sayama K; Shiraishi S; Shirakata Y; Kobayashi Y; Okada N; Okada H; Miki Y
Clin Exp Immunol; 1990 Nov; 82(2):355-8. PubMed ID: 2242615
[TBL] [Abstract][Full Text] [Related]
13. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions.
Seifert PS; Roth I; Schmiedt W; Oelert H; Okada N; Okada H; Bhakdi S
Atherosclerosis; 1992 Oct; 96(2-3):135-45. PubMed ID: 1281630
[TBL] [Abstract][Full Text] [Related]
14. Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.
Martin DE; Zalman LS; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):213-7. PubMed ID: 2963326
[TBL] [Abstract][Full Text] [Related]
15. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
16. Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study.
Tamai H; Matsuo S; Fukatsu A; Nishikawa K; Sakamoto N; Yoshioka K; Okada N; Okada H
Clin Exp Immunol; 1991 May; 84(2):256-62. PubMed ID: 1709070
[TBL] [Abstract][Full Text] [Related]
17. Rapid transformant selection by human complement using HRF20 (CD59) cDNA as a selection marker.
Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
Eur J Immunol; 1993 Oct; 23(10):2714-6. PubMed ID: 7691615
[TBL] [Abstract][Full Text] [Related]
18. CD59: a molecule involved in antigen presentation as well as downregulation of membrane attack complex.
Venneker GT; Asghar SS
Exp Clin Immunogenet; 1992; 9(1):33-47. PubMed ID: 1379443
[TBL] [Abstract][Full Text] [Related]
19. Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.
Tada T; Okada H; Okada N; Tateyama H; Suzuki H; Takahashi Y; Eimoto T
Virchows Arch; 1997 Apr; 430(4):327-32. PubMed ID: 9134044
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
Hayashi S; Isobe K; Emi N; Yokoyama I; Okada H; Nakashima I; Takagi H
Eur Surg Res; 1996; 28(6):440-6. PubMed ID: 8954321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
